UOB JAIC VENTURE BIO INVESTMENTS LTD.

Business Description

UOB JAIC VENTURE BIO INVESTMENTS LTD. is registered as a business entity on 31 October 2001 (23.3 years ago) structured as a Public Company Limited By Shares (Local Company) with 5 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) 200107096R. The business official address is located at 16 Raffles Quay #22-00, Hong Leong Building, Singapore 48581 in the primary industry of 66304: Private Equity Firms using Singapore Dollars - SGD as its default trading currency. The business legal name has undergone change(s) and is previously known as UOB VENTURE BIO INVESTMENTS LTD. The business annual account filing date falls on 19 September and is no longer operational with the status of 'Dissolved - Members' Voluntary Winding Up'. The business paid up share capital is USD 18,016, with preference share capital of USD 0, and other share capital at USD 0.

In the past 365 days, UOB JAIC VENTURE BIO INVESTMENTS LTD. has received a total of Login to view reported payment review(s). 0 were rated Good and Login to view were rated Poor. Therefore no payment reviews were made recently. The aggregated good payment amount is equivalent to USD 0, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "D" suggest a bad payment culture where settlement with stakeholders is frequently past due. Since the business is no longer active, please take caution if you continue transacting as a counter-party. The appointment of ERNST & YOUNG LLP as auditor indicates that the business is medium to large sized as it is required to meet additional regulatory requirements either due to reported revenue or assets exceeding SGD 10 million or has more than 50 employees in the previous two fiscal years.

UOB JAIC VENTURE BIO INVESTMENTS LTD. is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023